Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.

导出 OA

翻译打印收藏纠错

作者： Joanna,Luczkowiak ^[1] ; Gonzalo,Rivas ^[2] ; Nuria,Labiod ^[1] ; Fátima,Lasala ^[1] ; Marta,Rolo ^[2] ; Jaime,Lora-Tamayo ^[3] ; Mikel,Mancheno-Losa ^[4] ; David,Rial-Crestelo ^[3] ; Alfredo,Pérez-Rivilla ^[3] ; María Dolores,Folgueira ^[2] ; Rafael,Delgado ^[5]

作者单位： Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain. ^[1] Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain. ^[2] Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain. ^[3] CIBER de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain. ^[4] Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain. ^[5]

关键词 COVID-19 Omicron SARS-CoV-2 avidity neutralizing antibodies vaccines variants of concern

主题词人类(Humans);RNA, 信使(RNA, Messenger);抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral)

DOI 10.1002/jmv.28268

PMID 36319593

发布时间 2023-02-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交